Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B

For long-term treatment of hepatitis B virus (HBV) infection, switching from tenofovir-disoproxil-fumarate (TDF) to tenofovir-alafenamide (TAF) may prevent renal dysfunction and bone loss. However, the precise effects of this switch on the blood lipid profile remain to be clarified. This is an impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kazuharu, Suda, Goki, Yamamoto, Yoshiya, Abiko, Satoshi, Kinoshita, Kenji, Miyamoto, Shuichi, Sugiura, Ryo, Kimura, Megumi, Maehara, Osamu, Yamada, Ren, Kitagataya, Takashi, Shigesawa, Taku, Ohara, Masatsugu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775237/
https://www.ncbi.nlm.nih.gov/pubmed/35051189
http://dx.doi.org/10.1371/journal.pone.0261760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775237/
https://www.ncbi.nlm.nih.gov/pubmed/35051189
http://dx.doi.org/10.1371/journal.pone.0261760

Ejemplares similares